Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies

Area of Science:

• Hepatology
• Metabolic Disorders
• Molecular Medicine

Background:

• The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing globally, paralleling the obesity epidemic.
• Metabolic syndrome is a significant comorbidity associated with NAFLD.
• Current therapeutic options for NAFLD are limited, necessitating research into novel treatment strategies.

Purpose of the Study:

• To review emerging molecular mechanisms underlying NAFLD and associated metabolic disorders.
• To discuss the therapeutic implications of these molecular targets for NAFLD pharmacotherapy.
• To outline basic research identifying potential molecular targets for drug development.

Main Methods:

• Literature review of recent research on NAFLD molecular mechanisms.
• Analysis of studies identifying therapeutic targets for NAFLD.
• Synthesis of information on the link between metabolic disorders and NAFLD pathogenesis.

Main Results:

• Identification of several key molecular pathways implicated in NAFLD development.
• Discussion of potential pharmacotherapeutic targets based on emerging research.
• Overview of the translational potential of basic science findings for clinical application.

Conclusions:

• Emerging molecular targets show promise for the development of novel NAFLD treatments.
• Targeting specific molecular mechanisms could address both NAFLD and associated metabolic dysfunctions.
• Further research is crucial to translate these findings into effective pharmacotherapies.